Metabolite extract of Streptomyces hygroscopicus Hygroscopicus inhibit the growth of Plasmodium berghei through inhibition of ubiquitin - proteasome system
Streptomyces hygroscopicus Hygroscopicus, a member of family of Actinomycetes produces eponemycin a proteasome inhibitor that can inhibit Ubiquitin-Proteasome System (UPS) function in eukaryotic cell. Previous study showed that coronamycin, an active substrate isolated from Streptomyces sp. can act...
Gespeichert in:
Veröffentlicht in: | Tropical biomedicine 2013-06, Vol.30 (2), p.291-300 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 300 |
---|---|
container_issue | 2 |
container_start_page | 291 |
container_title | Tropical biomedicine |
container_volume | 30 |
creator | Rivo, Y B Alkarimah, A Ramadhani, N N Cahyono, A W Laksmi, D A Winarsih, S Fitri, L E |
description | Streptomyces hygroscopicus Hygroscopicus, a member of family of Actinomycetes produces eponemycin a proteasome inhibitor that can inhibit Ubiquitin-Proteasome System (UPS) function in eukaryotic cell. Previous study showed that coronamycin, an active substrate isolated from Streptomyces sp. can act as anti-plasmodial, antibacterial, and antifungal, however the research did not show the mechanism of coronamycin in inhibiting the growth of Plasmodium. This research was done to reveal if eponemycin that is contained in metabolite extract of S. hygroscopicus can inhibit UPS function of Plasmodium berghei. This study was an experimental study using P. berghei infected Balb/C mice as malaria model. Samples were divided into 1 control group (group infected with P. berghei without treatment) and 3 treatment groups (mice infected with P. berghei and treated intra-peritoneal with metabolite extract of S. hygroscopicus dose 130 μg/kgBW, 580 μg/kgBW, and 2600 μg/kgBW for 5 days). The degree of parasitemia and morphology of the parasite were measured from the first day of malaria induction until the last treatment. The accumulation level of polyubiquitin was measured using Western blot and ELISA method. The degree of parasitemia on day 6 showed significant differences among treatment groups and control (p=0,000). Percentage of inhibition showed significant differences between control and group treated with metabolite extract of S. hygroscopicus 2600 μg/kgBW. An increasing dose of extract of S. hygroscopicus followed by an increasing of inhibition in parasite growth (r=0,850). Probit analysis showed that ED50 was 9.418 μg/kgBW. There was a change in morphology of the parasite after treatment. Parasite morphology became crisis form. There was an accumulation of polyubiquitinated protein in the group treated with metabolite extract of S. hygroscopicus 2600 μg/kgBW. It can be concluded that analog eponemycin in metabolite of S. hygroscopicus is a potential candidate for new malarial drug by inhibiting UPS function of the parasite and cause stress and dead of the parasite. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1426749845</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1426749845</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-55ecaa319b49d86a8a789dce7f64e5668d1545dd50027957f893ad1d402667153</originalsourceid><addsrcrecordid>eNpVkM1OwzAQhHMA0VJ4BeQjl0hxYsf2EVVAkYpAAs6RE28aozhO_SPIs_CypKI9cFrN6pvRaM6SZYZzllKWZ4vk0vvPLKOEc3KRLPJCUEEEXSY_zxBkbXsdAMF3cLIJyLboLTgYgzVTAx51085Z39hRN9GjzT-lh07XOqDQAZr_X6E72F976Y1VOhpUg9t1oGfA2bjrTgZthwMYa72PsxpQikZnA0hvDSA_-QDmKjlvZe_h-nhXycfD_ft6k25fHp_Wd9t0zDEOKaXQSFlgUROheCm5ZFyoBlhbEqBlyRWmhCpFsyxngrKWi0IqrEiWlyXDtFglt3-5c4N9BB8qo30DfS8HsNFXmOQlI4KTA3pzRGNtQFWj00a6qToNWvwCInh1YA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1426749845</pqid></control><display><type>article</type><title>Metabolite extract of Streptomyces hygroscopicus Hygroscopicus inhibit the growth of Plasmodium berghei through inhibition of ubiquitin - proteasome system</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Rivo, Y B ; Alkarimah, A ; Ramadhani, N N ; Cahyono, A W ; Laksmi, D A ; Winarsih, S ; Fitri, L E</creator><creatorcontrib>Rivo, Y B ; Alkarimah, A ; Ramadhani, N N ; Cahyono, A W ; Laksmi, D A ; Winarsih, S ; Fitri, L E</creatorcontrib><description>Streptomyces hygroscopicus Hygroscopicus, a member of family of Actinomycetes produces eponemycin a proteasome inhibitor that can inhibit Ubiquitin-Proteasome System (UPS) function in eukaryotic cell. Previous study showed that coronamycin, an active substrate isolated from Streptomyces sp. can act as anti-plasmodial, antibacterial, and antifungal, however the research did not show the mechanism of coronamycin in inhibiting the growth of Plasmodium. This research was done to reveal if eponemycin that is contained in metabolite extract of S. hygroscopicus can inhibit UPS function of Plasmodium berghei. This study was an experimental study using P. berghei infected Balb/C mice as malaria model. Samples were divided into 1 control group (group infected with P. berghei without treatment) and 3 treatment groups (mice infected with P. berghei and treated intra-peritoneal with metabolite extract of S. hygroscopicus dose 130 μg/kgBW, 580 μg/kgBW, and 2600 μg/kgBW for 5 days). The degree of parasitemia and morphology of the parasite were measured from the first day of malaria induction until the last treatment. The accumulation level of polyubiquitin was measured using Western blot and ELISA method. The degree of parasitemia on day 6 showed significant differences among treatment groups and control (p=0,000). Percentage of inhibition showed significant differences between control and group treated with metabolite extract of S. hygroscopicus 2600 μg/kgBW. An increasing dose of extract of S. hygroscopicus followed by an increasing of inhibition in parasite growth (r=0,850). Probit analysis showed that ED50 was 9.418 μg/kgBW. There was a change in morphology of the parasite after treatment. Parasite morphology became crisis form. There was an accumulation of polyubiquitinated protein in the group treated with metabolite extract of S. hygroscopicus 2600 μg/kgBW. It can be concluded that analog eponemycin in metabolite of S. hygroscopicus is a potential candidate for new malarial drug by inhibiting UPS function of the parasite and cause stress and dead of the parasite.</description><identifier>ISSN: 0127-5720</identifier><identifier>PMID: 23959495</identifier><language>eng</language><publisher>Malaysia</publisher><subject>Animals ; Antimalarials - isolation & purification ; Antimalarials - therapeutic use ; Blotting, Western ; Disease Models, Animal ; Enzyme Inhibitors - isolation & purification ; Enzyme Inhibitors - therapeutic use ; Enzyme-Linked Immunosorbent Assay ; Malaria - drug therapy ; Malaria - parasitology ; Male ; Mice ; Mice, Inbred BALB C ; Parasitemia - drug therapy ; Parasitemia - parasitology ; Plasmodium ; Plasmodium berghei - cytology ; Plasmodium berghei - drug effects ; Polyubiquitin - analysis ; Proteasome Endopeptidase Complex - drug effects ; Streptomyces - metabolism ; Treatment Outcome ; Ubiquitin - antagonists & inhibitors</subject><ispartof>Tropical biomedicine, 2013-06, Vol.30 (2), p.291-300</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23959495$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rivo, Y B</creatorcontrib><creatorcontrib>Alkarimah, A</creatorcontrib><creatorcontrib>Ramadhani, N N</creatorcontrib><creatorcontrib>Cahyono, A W</creatorcontrib><creatorcontrib>Laksmi, D A</creatorcontrib><creatorcontrib>Winarsih, S</creatorcontrib><creatorcontrib>Fitri, L E</creatorcontrib><title>Metabolite extract of Streptomyces hygroscopicus Hygroscopicus inhibit the growth of Plasmodium berghei through inhibition of ubiquitin - proteasome system</title><title>Tropical biomedicine</title><addtitle>Trop Biomed</addtitle><description>Streptomyces hygroscopicus Hygroscopicus, a member of family of Actinomycetes produces eponemycin a proteasome inhibitor that can inhibit Ubiquitin-Proteasome System (UPS) function in eukaryotic cell. Previous study showed that coronamycin, an active substrate isolated from Streptomyces sp. can act as anti-plasmodial, antibacterial, and antifungal, however the research did not show the mechanism of coronamycin in inhibiting the growth of Plasmodium. This research was done to reveal if eponemycin that is contained in metabolite extract of S. hygroscopicus can inhibit UPS function of Plasmodium berghei. This study was an experimental study using P. berghei infected Balb/C mice as malaria model. Samples were divided into 1 control group (group infected with P. berghei without treatment) and 3 treatment groups (mice infected with P. berghei and treated intra-peritoneal with metabolite extract of S. hygroscopicus dose 130 μg/kgBW, 580 μg/kgBW, and 2600 μg/kgBW for 5 days). The degree of parasitemia and morphology of the parasite were measured from the first day of malaria induction until the last treatment. The accumulation level of polyubiquitin was measured using Western blot and ELISA method. The degree of parasitemia on day 6 showed significant differences among treatment groups and control (p=0,000). Percentage of inhibition showed significant differences between control and group treated with metabolite extract of S. hygroscopicus 2600 μg/kgBW. An increasing dose of extract of S. hygroscopicus followed by an increasing of inhibition in parasite growth (r=0,850). Probit analysis showed that ED50 was 9.418 μg/kgBW. There was a change in morphology of the parasite after treatment. Parasite morphology became crisis form. There was an accumulation of polyubiquitinated protein in the group treated with metabolite extract of S. hygroscopicus 2600 μg/kgBW. It can be concluded that analog eponemycin in metabolite of S. hygroscopicus is a potential candidate for new malarial drug by inhibiting UPS function of the parasite and cause stress and dead of the parasite.</description><subject>Animals</subject><subject>Antimalarials - isolation & purification</subject><subject>Antimalarials - therapeutic use</subject><subject>Blotting, Western</subject><subject>Disease Models, Animal</subject><subject>Enzyme Inhibitors - isolation & purification</subject><subject>Enzyme Inhibitors - therapeutic use</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Malaria - drug therapy</subject><subject>Malaria - parasitology</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Parasitemia - drug therapy</subject><subject>Parasitemia - parasitology</subject><subject>Plasmodium</subject><subject>Plasmodium berghei - cytology</subject><subject>Plasmodium berghei - drug effects</subject><subject>Polyubiquitin - analysis</subject><subject>Proteasome Endopeptidase Complex - drug effects</subject><subject>Streptomyces - metabolism</subject><subject>Treatment Outcome</subject><subject>Ubiquitin - antagonists & inhibitors</subject><issn>0127-5720</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkM1OwzAQhHMA0VJ4BeQjl0hxYsf2EVVAkYpAAs6RE28aozhO_SPIs_CypKI9cFrN6pvRaM6SZYZzllKWZ4vk0vvPLKOEc3KRLPJCUEEEXSY_zxBkbXsdAMF3cLIJyLboLTgYgzVTAx51085Z39hRN9GjzT-lh07XOqDQAZr_X6E72F976Y1VOhpUg9t1oGfA2bjrTgZthwMYa72PsxpQikZnA0hvDSA_-QDmKjlvZe_h-nhXycfD_ft6k25fHp_Wd9t0zDEOKaXQSFlgUROheCm5ZFyoBlhbEqBlyRWmhCpFsyxngrKWi0IqrEiWlyXDtFglt3-5c4N9BB8qo30DfS8HsNFXmOQlI4KTA3pzRGNtQFWj00a6qToNWvwCInh1YA</recordid><startdate>201306</startdate><enddate>201306</enddate><creator>Rivo, Y B</creator><creator>Alkarimah, A</creator><creator>Ramadhani, N N</creator><creator>Cahyono, A W</creator><creator>Laksmi, D A</creator><creator>Winarsih, S</creator><creator>Fitri, L E</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201306</creationdate><title>Metabolite extract of Streptomyces hygroscopicus Hygroscopicus inhibit the growth of Plasmodium berghei through inhibition of ubiquitin - proteasome system</title><author>Rivo, Y B ; Alkarimah, A ; Ramadhani, N N ; Cahyono, A W ; Laksmi, D A ; Winarsih, S ; Fitri, L E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-55ecaa319b49d86a8a789dce7f64e5668d1545dd50027957f893ad1d402667153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Antimalarials - isolation & purification</topic><topic>Antimalarials - therapeutic use</topic><topic>Blotting, Western</topic><topic>Disease Models, Animal</topic><topic>Enzyme Inhibitors - isolation & purification</topic><topic>Enzyme Inhibitors - therapeutic use</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Malaria - drug therapy</topic><topic>Malaria - parasitology</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Parasitemia - drug therapy</topic><topic>Parasitemia - parasitology</topic><topic>Plasmodium</topic><topic>Plasmodium berghei - cytology</topic><topic>Plasmodium berghei - drug effects</topic><topic>Polyubiquitin - analysis</topic><topic>Proteasome Endopeptidase Complex - drug effects</topic><topic>Streptomyces - metabolism</topic><topic>Treatment Outcome</topic><topic>Ubiquitin - antagonists & inhibitors</topic><toplevel>online_resources</toplevel><creatorcontrib>Rivo, Y B</creatorcontrib><creatorcontrib>Alkarimah, A</creatorcontrib><creatorcontrib>Ramadhani, N N</creatorcontrib><creatorcontrib>Cahyono, A W</creatorcontrib><creatorcontrib>Laksmi, D A</creatorcontrib><creatorcontrib>Winarsih, S</creatorcontrib><creatorcontrib>Fitri, L E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Tropical biomedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rivo, Y B</au><au>Alkarimah, A</au><au>Ramadhani, N N</au><au>Cahyono, A W</au><au>Laksmi, D A</au><au>Winarsih, S</au><au>Fitri, L E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolite extract of Streptomyces hygroscopicus Hygroscopicus inhibit the growth of Plasmodium berghei through inhibition of ubiquitin - proteasome system</atitle><jtitle>Tropical biomedicine</jtitle><addtitle>Trop Biomed</addtitle><date>2013-06</date><risdate>2013</risdate><volume>30</volume><issue>2</issue><spage>291</spage><epage>300</epage><pages>291-300</pages><issn>0127-5720</issn><abstract>Streptomyces hygroscopicus Hygroscopicus, a member of family of Actinomycetes produces eponemycin a proteasome inhibitor that can inhibit Ubiquitin-Proteasome System (UPS) function in eukaryotic cell. Previous study showed that coronamycin, an active substrate isolated from Streptomyces sp. can act as anti-plasmodial, antibacterial, and antifungal, however the research did not show the mechanism of coronamycin in inhibiting the growth of Plasmodium. This research was done to reveal if eponemycin that is contained in metabolite extract of S. hygroscopicus can inhibit UPS function of Plasmodium berghei. This study was an experimental study using P. berghei infected Balb/C mice as malaria model. Samples were divided into 1 control group (group infected with P. berghei without treatment) and 3 treatment groups (mice infected with P. berghei and treated intra-peritoneal with metabolite extract of S. hygroscopicus dose 130 μg/kgBW, 580 μg/kgBW, and 2600 μg/kgBW for 5 days). The degree of parasitemia and morphology of the parasite were measured from the first day of malaria induction until the last treatment. The accumulation level of polyubiquitin was measured using Western blot and ELISA method. The degree of parasitemia on day 6 showed significant differences among treatment groups and control (p=0,000). Percentage of inhibition showed significant differences between control and group treated with metabolite extract of S. hygroscopicus 2600 μg/kgBW. An increasing dose of extract of S. hygroscopicus followed by an increasing of inhibition in parasite growth (r=0,850). Probit analysis showed that ED50 was 9.418 μg/kgBW. There was a change in morphology of the parasite after treatment. Parasite morphology became crisis form. There was an accumulation of polyubiquitinated protein in the group treated with metabolite extract of S. hygroscopicus 2600 μg/kgBW. It can be concluded that analog eponemycin in metabolite of S. hygroscopicus is a potential candidate for new malarial drug by inhibiting UPS function of the parasite and cause stress and dead of the parasite.</abstract><cop>Malaysia</cop><pmid>23959495</pmid><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0127-5720 |
ispartof | Tropical biomedicine, 2013-06, Vol.30 (2), p.291-300 |
issn | 0127-5720 |
language | eng |
recordid | cdi_proquest_miscellaneous_1426749845 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Animals Antimalarials - isolation & purification Antimalarials - therapeutic use Blotting, Western Disease Models, Animal Enzyme Inhibitors - isolation & purification Enzyme Inhibitors - therapeutic use Enzyme-Linked Immunosorbent Assay Malaria - drug therapy Malaria - parasitology Male Mice Mice, Inbred BALB C Parasitemia - drug therapy Parasitemia - parasitology Plasmodium Plasmodium berghei - cytology Plasmodium berghei - drug effects Polyubiquitin - analysis Proteasome Endopeptidase Complex - drug effects Streptomyces - metabolism Treatment Outcome Ubiquitin - antagonists & inhibitors |
title | Metabolite extract of Streptomyces hygroscopicus Hygroscopicus inhibit the growth of Plasmodium berghei through inhibition of ubiquitin - proteasome system |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T07%3A30%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolite%20extract%20of%20Streptomyces%20hygroscopicus%20Hygroscopicus%20inhibit%20the%20growth%20of%20Plasmodium%20berghei%20through%20inhibition%20of%20ubiquitin%20-%20proteasome%20system&rft.jtitle=Tropical%20biomedicine&rft.au=Rivo,%20Y%20B&rft.date=2013-06&rft.volume=30&rft.issue=2&rft.spage=291&rft.epage=300&rft.pages=291-300&rft.issn=0127-5720&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1426749845%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1426749845&rft_id=info:pmid/23959495&rfr_iscdi=true |